BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Update

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 191,200 shares, a growth of 38.8% from the December 15th total of 137,800 shares. Based on an average daily volume of 98,300 shares, the days-to-cover ratio is presently 1.9 days.

BioStem Technologies Trading Up 0.8 %

Shares of OTCMKTS BSEM traded up $0.12 on Friday, reaching $15.72. 21,158 shares of the company traded hands, compared to its average volume of 40,726. The stock has a market capitalization of $261.74 million, a PE ratio of 23.12 and a beta of -0.53. BioStem Technologies has a fifty-two week low of $4.41 and a fifty-two week high of $28.26. The company has a 50 day moving average of $15.28 and a 200 day moving average of $12.65.

BioStem Technologies (OTCMKTS:BSEM) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.01. The company had revenue of $82.56 million for the quarter, compared to analysts’ expectations of $78.22 million. As a group, research analysts expect that BioStem Technologies will post 1.41 earnings per share for the current year.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.